Your browser is no longer supported. Please, upgrade your browser.
Order: Signal: Tickers:
Filters: 0    Descriptive       Fundamental       Technical       All   
Exchange Index Sector Industry Country
Market Cap. Dividend Yield Float Short Analyst Recom. Option/Short
Earnings Date Average Volume Relative Volume Current Volume Price
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 9 #1
CompanyAviat Networks, Inc.
IndustryCommunication Equipment
Market Cap79.20MEPS (ttm)-0.60
P/E-EPS this Y-372.20%
Forward P/E-EPS next Y90.90%
PEG-EPS past 5Y32.20%
P/S0.23EPS next 5Y12.00%
P/B0.86EPS Q/Q70.60%
Dividend-Sales Q/Q7.80%
Insider Own3.60%Inst Own69.20%
Insider Trans-0.67%Inst Trans2.53%
Short Float1.64%EarningsJan 29/a
Analyst Recom2.00Target Price1.90
Avg Volume160.63K52W Range0.99 - 2.07
Feb-26-15 04:05PMAviat Closes Multiple Deals with Major African Mobile Operator PR Newswire
Feb-24-15 09:00AMAviat Wins $9 Million Deal for North American LTE Network PR Newswire
Feb-11-15 01:04PMAVIAT NETWORKS, INC. Financials EDGAR Online Financials
Feb-06-15 07:07PM10-Q for Aviat Networks, Inc. Company Spotlight
Jan-29-15 07:19PMAviat reports 2Q loss AP
Jan-29-15 04:30PMAviat Networks Inc Earnings Call scheduled for 4:30 pm ET today CCBN
Jan-29-15 04:05PMAviat Networks Announces Fiscal Second Quarter 2015 Financial Results PR Newswire
Jan-29-15 08:18AMQualcomm Beats Q1 Earnings & Revenues, Guidance Slashed - Analyst Blog Zacks
Jan-29-15 07:07AMQ2 2015 Aviat Networks Inc Earnings Release - After Market Close CCBN
Jan-28-15 10:30AMEricsson Q4 Earnings Miss on Dismal North America Business - Analyst Blog Zacks
Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services in North America and Internationally. It offers point-to-point digital microwave transmission systems for first/last mile access, middle mile/backhaul, and long distance trunking applications. The company's products include network management software solutions to enable operators to deploy, monitor, and manage its systems, as well as third party equipment, such as antennas, routers, and multiplexers to build and deploy a wireless transmission network and a suite of turnkey support services. It also provides broadband wireless access base stations and customer premises equipment for fixed and mobile; point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications; and supporting network deployments, network expansion, and capacity upgrades. In addition, the company offers various professional services, such as network planning and design, site surveys and builds, systems integration, installation, maintenance, network monitoring, training, customer services, and other professional services. It serves wireless/mobile service providers, original equipment manufacturers, distributors, and system integrators; private network users, such as public safety agencies and government institutions; and utility, pipeline, railroad, and other industrial enterprises that operate broadband wireless networks. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAHBAZIAN MICHAELCFO (interim)Feb 02Sale1.2710,20912,96534,235Feb 02 06:51 PM
Stumpe HeinzSVP & Chief Sales OfficerSep 09Sale1.532,4013,674116,980Sep 10 02:18 PM
Elliott Meena L.SVP, Gen. Counsel & SecretarySep 09Sale1.531,5842,42499,632Sep 10 02:19 PM
Madigan JohnVP, Corporate Controller & PAOSep 09Sale1.531,0051,53851,829Sep 10 02:17 PM
Stumpe HeinzSVP & Chief Sales OfficerJun 30Sale1.205,4926,593119,381Jul 01 12:36 PM
CompanyDyax Corp.
Market Cap2.06BEPS (ttm)-0.09
P/E-EPS this Y65.40%
Forward P/E-EPS next Y72.20%
PEG-EPS past 5Y36.90%
P/S25.23EPS next 5Y18.60%
P/B19.62EPS Q/Q0.00%
Dividend-Sales Q/Q53.80%
Insider Own0.30%Inst Own96.60%
Insider Trans-35.95%Inst Trans-1.06%
Short Float3.35%EarningsFeb 24/b
Analyst Recom1.60Target Price17.06
Avg Volume961.70K52W Range6.05 - 17.20
Mar-01-15 07:09PM10-K for Dyax Corp. Company Spotlight
Feb-27-15 04:21PMDYAX CORP Files SEC form 10-K, Annual Report EDGAR Online
Feb-24-15 11:58AMDyax reports 4Q loss AP
Feb-24-15 07:21AMDYAX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
Feb-24-15 07:07AMQ4 2014 Dyax Corp Earnings Release - Time Not Supplied CCBN
Feb-24-15 07:01AMDyax Corp. Announces Fourth Quarter and Full Year 2014 Financial Results Business Wire
Feb-18-15 08:00AMDyax Corp. to Participate in Upcoming Investor Conferences Business Wire
Feb-12-15 02:35PMDyax aims at preventative treatment for rare swelling disease at
Feb-10-15 08:00AMDyax Corp. to Host Fourth Quarter and Year End 2014 Earnings Call and Webcast Business Wire
Feb-04-15 04:15PMDyax Corp. to Participate in the Leerink Partners 2015 Global Healthcare Conference Business Wire
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. The company offers KALBITOR for the treatment of acute attacks of HAE. It is developing DX-2930, a human monoclonal antibody inhibitor of plasma kallikrein, which would be a candidate to prophylactically treat HAE and other PKM disorders. The company distributes KALBITOR through a network of wholesale and specialty pharmacy arrangements. It has agreements with CVie Therapeutics for the development and commercialization of KALBITOR in the treatment of HAE and other angioedema indications in China; and Novellus Biopharma AG for the development and commercialization of KALBITOR for the treatment of HAE and other angioedema indications in Latin America, including Argentina, Brazil, Chile, Colombia, Mexico, and Venezuela. The company also has a strategic collaboration agreement with Sigma-Tau Rare Diseases S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia. Dyax Corp. was founded in 1989 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ashe Andrew D.General Counsel & EVPFeb 26Sale15.341,50023,01036,527Feb 26 04:29 PM
MIGAUSKY GEORGE VEVP & Chief Financial OfficerFeb 24Sale15.649,000140,78876,350Feb 26 04:28 PM
Christensen GustavCEO and PresidentFeb 24Sale15.6418,750293,219218,750Feb 26 04:28 PM
ADELMAN BURT ACMO & EVP, R&DJan 02Option Exercise1.4875,000111,000112,500Jan 05 06:43 PM
ADELMAN BURT ACMO & EVP, R&DJan 02Sale14.0575,0001,053,86337,500Jan 05 06:43 PM
TickerKOS [NYSE]
CompanyKosmos Energy Ltd.
IndustryIndependent Oil & Gas
Market Cap3.48BEPS (ttm)0.71
P/E12.65EPS this Y400.00%
Forward P/E-EPS next Y20.80%
PEG0.55EPS past 5Y32.30%
P/S4.05EPS next 5Y22.85%
P/B2.55EPS Q/Q2991.00%
Dividend-Sales Q/Q-17.00%
Insider Own1.50%Inst Own92.20%
Insider Trans-88.82%Inst Trans0.81%
Short Float2.59%EarningsFeb 23/b
Analyst Recom2.30Target Price10.77
Avg Volume1.97M52W Range6.96 - 11.27
Mar-02-15 02:00AMKosmos Energy Provides Update on 2015 Exploration Drilling Program Business Wire
Feb-27-15 01:04PMKOSMOS ENERGY LTD. Financials EDGAR Online Financials
Feb-23-15 04:29PMKosmos Energy (KOS) Stock Declined Today on Wider Than Expected Losses at TheStreet
Feb-23-15 11:00AMKosmos Energy Ltd Earnings Call scheduled for 11:00 am ET today CCBN
Feb-23-15 09:36AMKosmos Energy misses 4Q profit forecasts AP
Feb-23-15 08:40AMKOSMOS ENERGY LTD. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Finan EDGAR Online
Feb-23-15 08:00AMKosmos Energy Announces Fourth Quarter and Full Year 2014 Results Business Wire
Feb-23-15 07:07AMQ4 2014 Kosmos Energy Ltd Earnings Release - Before Market Open CCBN
Feb-18-15 08:00AMKosmos Energy to Present at Credit Suisse 20th Annual Energy Summit Business Wire
Feb-11-15 09:30AMThe Zacks Analyst Blog Highlights: BP, Suncor Energy, Marathon Petroleum, Chevron and Kosmos Energy - Press Releases Zacks
Kosmos Energy Ltd. explores for and produces oil and gas in Africa, Europe, and South America. Its asset portfolio includes production and other development projects in offshore Ghana, as well as exploration licenses with hydrocarbon potential in offshore Ireland, Mauritania, Morocco, Senegal, and Suriname. The company was founded in 2003 and is based in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BCP IV GP L.L.C.10% OwnerOct 10Sale9.336,749,99562,977,453270,001Oct 10 05:36 PM
Blackstone Holdings III L.P.10% OwnerOct 10Sale9.336,750,00062,977,500270,001Oct 10 05:35 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.337,951,43774,186,90756,556,832Oct 15 01:50 PM
WARBURG PINCUS & CO.DirectorOct 10Sale9.3316,500,000153,945,000118,008,651Oct 15 01:50 PM
Krieger David BenjaminDirectorOct 10Sale9.338,250,00076,972,500118,008,651Oct 15 01:54 PM
CompanyMaiden Holdings, Ltd.
IndustryProperty & Casualty Insurance
Market Cap1.04BEPS (ttm)0.89
P/E16.08EPS this Y79.70%
Forward P/E7.12EPS next Y9.72%
PEG1.34EPS past 5Y29.20%
P/S0.46EPS next 5Y12.00%
P/B1.16EPS Q/Q20.00%
Dividend3.63%Sales Q/Q16.70%
Insider Own5.50%Inst Own74.70%
Insider Trans0.00%Inst Trans4.22%
Short Float7.00%EarningsFeb 18/a
Analyst Recom1.60Target Price16.00
Avg Volume331.31K52W Range10.80 - 14.83
Feb-27-15 04:16PMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
Feb-19-15 10:25AMCompass Point Sees Higher-Than-Expected Premium Growth For Maiden Holdings Benzinga
Feb-19-15 08:41AMMaiden Holdings Beats on Q4 Earnings as Revenues Grow - Analyst Blog Zacks
Feb-19-15 08:30AMMaiden Holdings Ltd Earnings Call scheduled for 8:30 am ET today CCBN
Feb-19-15 06:03AMMAIDEN HOLDINGS, LTD. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Feb-19-15 05:03AMMaiden Holdings beats 4Q profit forecasts AP
Feb-18-15 04:12PMMaiden Holdings, Ltd. Announces Fourth Quarter 2014 Net Operating Earnings(1) of $34.6 million or $0.44 Per Diluted Common Share and Annualized Operating Return on Common Equity(1) of 15.1%; Full Year 2014 Annualized Operating Return on Com GlobeNewswire
Feb-18-15 07:07AMQ4 2014 Maiden Holdings Ltd Earnings Release - After Market Close CCBN
Feb-16-15 03:06PMMaiden Holdings Announces Dividends on Common Shares and Preference Shares GlobeNewswire
Jan-29-15 09:05AMMaiden Holdings, Ltd. to Release Fourth Quarter 2014 Earnings on February 18, 2015 and Host Conference Call on February 19, 2015 GlobeNewswire
Maiden Holdings, Ltd., together with its subsidiaries, provides reinsurance solutions to regional and specialty insurers in the United States, Europe, and internationally. The company operates through three segments: Diversified Reinsurance, AmTrust Quota Share Reinsurance, and NGHC Quota Share. The Diversified Reinsurance segment offers property, casualty, accident, and health reinsurance products through the treaties with other insurers on a quota share or excess of loss basis, as well as on a facultative basis primarily through third-party intermediaries and on a direct basis. The AmTrust Quota Share Reinsurance segment provides small commercial business insurance, which includes workers' compensation, commercial package, and other property and casualty insurance products; specialty risk and extended warranty coverage for consumer and commercial goods, as well as custom designed coverage, including accidental damage plans and payment protection plans in connection with the sale of consumer and commercial goods; and specialty program that comprises package products, general liability, commercial auto liability, excess and surplus lines programs, and other specialty commercial property and casualty insurance to small and middle market companies. The NGHC Quota Share segment reinsures personal lines automobile business under the quota share reinsurance agreement. The company also offers credit life reinsurance. The company was founded in 2007 and is headquartered in Hamilton, Bermuda.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 19Option Exercise0.0023,4330347,725Feb 19 07:32 PM
RASCHBAUM ARTURO MANUELPRESIDENT AND CEOFeb 18Option Exercise0.0049,9000324,392Feb 19 07:32 PM
SCHMITT KARENChief Financial OfficerSep 03Option Exercise4.0024,17596,610111,324Sep 03 04:03 PM
NEFF RAYMOND MICHAELDirectorMar 27Option Exercise0.0024,0000249,000Mar 28 06:55 AM
MARSHALECK JOHNCHIEF FINANCIAL OFFICERMar 21Option Exercise3.2825,00082,00079,730Mar 24 05:04 PM
TickerMR [NYSE]
CompanyMindray Medical International Limited
IndustryMedical Instruments & Supplies
Market Cap3.31BEPS (ttm)1.84
P/E15.36EPS this Y24.70%
Forward P/E14.50EPS next Y7.68%
PEG-EPS past 5Y14.30%
P/S2.56EPS next 5Y-0.90%
P/B2.16EPS Q/Q56.00%
Dividend1.77%Sales Q/Q9.60%
Insider Own1.93%Inst Own-
Insider Trans0.00%Inst Trans-3.00%
Short Float13.44%EarningsMar 09/a
Analyst Recom2.60Target Price32.05
Avg Volume569.98K52W Range25.90 - 35.94
Feb-12-15 07:00AMMindray to Report 2014 Fourth Quarter and Full Year Financial Results on Mar 9, 2015 PR Newswire
Jan-22-15 07:00AMMindray Medical International Limited (MR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-16-15 09:30AMThe Zacks Analyst Blog Highlights: Bitauto Holdings,, Alibaba Group Holding, Citigroup and Mindray Medical International - Press Releases Zacks
Jan-15-15 02:36PMChina Stock Roundup: JD, Tencent to Invest $1.55B in Bitauto, Alibaba Pays $575M for Stake in One97 - Analyst Blog Zacks
Jan-12-15 06:55AMMindray Announces Preliminary 2014 Operating Results and 2015 Net Revenues Guidance PR Newswire
Jan-06-15 08:00AMMindray to Participate in Upcoming Investor Conferences and Events PR Newswire
Dec-12-14 05:00PMMindray Announced Shareholder Resolutions Post 2014 Annual General Meeting PR Newswire
Nov-24-14 07:30AMAmerican Biotech Start-Ups Head To China For Capital Partners at Forbes
Nov-13-14 06:00AMMindray to Hold Annual General Meeting in Hong Kong on December 10, 2014 PR Newswire
Nov-04-14 02:10PMMindray Medical Q3 Earnings in Line, 2014 View Lowered Zacks
Mindray Medical International Limited develops, manufactures, and markets medical devices worldwide. The company operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. The Patient Monitoring and Life Support Products segment offers monitoring devices that track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. Its products include single and multiple-parameter monitors; mobile and portable multifunction monitors; central stations that can collect and display multiple patient data on a single screen; electro-cardiogram monitoring devices; and veterinary monitoring devices. This segment also provides anesthesia machines; defibrillators; surgical equipment, including surgical beds, and surgical lights ceiling pendants; syringes and infusion pumps; and ventilators. The In-Vitro Diagnostic Products segment provides data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment; and in-vitro diagnostic products for laboratories, clinics, and hospitals to perform analysis to detect and quantify substances in patient samples. Its product portfolio consists of hematology analysis products, biochemistry analysis products, immunoassay products, coagulation analysis products, urine sediment analysis products, and microbiology analysis products; and reagents used in in-vitro diagnostic products. The Medical Imaging Systems segment offers ultrasound systems used in medical fields, such as urology, gynecology, obstetrics, and cardiology; digital radiography systems; and magnetic resonance imaging systems. The company also provides orthopedic products, endoscope devices, and healthcare IT solutions. It markets and sells its products through distributors, as well as directly to hospitals and government agencies. The company was founded in 1991 and is headquartered in Shenzhen, The People's Republic of China.
CompanyRepublic Airways Holdings Inc.
IndustryRegional Airlines
Market Cap643.76MEPS (ttm)1.23
P/E10.46EPS this Y33.70%
Forward P/E7.66EPS next Y14.44%
PEG0.46EPS past 5Y1.70%
P/S0.47EPS next 5Y22.71%
P/B1.04EPS Q/Q-28.10%
Dividend-Sales Q/Q-0.40%
Insider Own1.40%Inst Own83.90%
Insider Trans-25.51%Inst Trans-2.43%
Short Float2.61%EarningsFeb 25/a
Analyst Recom2.20Target Price15.60
Avg Volume503.41K52W Range7.82 - 15.36
Mar-01-15 07:09PM10-K for Republic Airways Holdings, Inc. Company Spotlight
Feb-27-15 04:10PMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-27-15 08:52AMImperial Capital Sees 4Q14 Results As Largely Consistent With Expectations For Republic Airways Holdings Benzinga
Feb-26-15 05:37PMCan Airline Stocks Keep Soaring On Low Fuel Costs? at Investor's Business Daily
Feb-25-15 04:29PMStocks End Mixed; Aruba Soars On Report Of HP Buyout at Investor's Business Daily
Feb-25-15 10:00AMRepublic Airways Holdings Inc Earnings Call scheduled for 10:00 am ET today CCBN
Feb-25-15 08:49AMREPUBLIC AIRWAYS HOLDINGS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements EDGAR Online
Feb-25-15 07:07AMQ4 2014 Republic Airways Holdings Inc Earnings Release - Time Not Supplied CCBN
Feb-25-15 05:03AMRepublic Airways posts 4Q profit AP
Feb-24-15 09:38PMRepublic Airways Holdings Reports Fourth Quarter and Full Year 2014 Financial Results Business Wire
Republic Airways Holdings Inc., through its subsidiaries, provides scheduled passenger services. It offers scheduled passenger service on approximately 1,390 flights daily to approximately 118 cities in the U.S. and Canada through fixed-fee flights operated under airline partner brands, including American Eagle, Delta Connection, United Express, and US Airways Express. As of December 31, 2013, the company operated a combined fleet of approximately 258 aircraft. It is also engaged in charter and cargo operations. The company was founded in 1996 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Allman JosephVP, Fin. P&AFeb 25Option Exercise12.707008,89036,533Feb 26 04:56 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryFeb 25Option Exercise10.291671,71860,167Feb 26 04:50 PM
Allman JosephVP, Fin. P&AFeb 25Sale15.0570010,53535,833Feb 26 04:56 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryFeb 24Option Exercise10.292,50025,72562,500Feb 26 04:50 PM
Dooley Timothy P.EVP, CFO, Treasurer, SecretaryFeb 24Sale15.002,66740,00560,000Feb 26 04:50 PM
CompanySangamo Biosciences Inc.
Market Cap1.16BEPS (ttm)-0.40
P/E-EPS this Y18.80%
Forward P/E-EPS next Y-15.80%
PEG-EPS past 5Y2.40%
P/S25.35EPS next 5Y-
P/B5.50EPS Q/Q53.80%
Dividend-Sales Q/Q117.40%
Insider Own1.50%Inst Own72.50%
Insider Trans-75.11%Inst Trans-4.68%
Short Float13.82%EarningsFeb 10/a
Analyst Recom1.60Target Price25.50
Avg Volume1.00M52W Range9.39 - 24.69
Feb-26-15 07:00AMSangamo BioSciences Presents New Clinical Data at CROI 2015 From Trial of ZFP Therapeutic® Designed to Provide Functional Control of HIV PR Newswire
Feb-25-15 04:30PMSANGAMO BIOSCIENCES INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-25-15 04:02PMSangamo BioSciences Announces Presentation At The Cowen And Company 35th Annual Health Care Conference PR Newswire
Feb-12-15 07:00AMSangamo BioSciences Presents Data At 11th Annual WorldSymposium Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders PR Newswire
Feb-10-15 05:18PMSangamo reports 4Q loss AP
Feb-10-15 05:00PMSangamo BioSciences Inc Earnings Call scheduled for 5:00 pm ET today CCBN
Feb-10-15 04:31PMSANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Shareholder Director Nomin EDGAR Online
Feb-10-15 04:02PMSangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Feb-10-15 07:07AMQ4 2014 Sangamo BioSciences Inc Earnings Release - After Market Close CCBN
Feb-09-15 01:10PMWill Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog Zacks
Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways; and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company's principal ZFP therapeutic is SB-728-T, a ZFN-modified autologous T-cell product, which is in Phase II and Phase I/II clinical trials for the treatment of human immunodeficiency virus and acquired immunodeficiency syndrome. It also develops CERE-110 that is in Phase II clinical trial for the treatment of Alzheimer's disease. In addition, the company has ZFP therapeutic pre-clinical stage programs for hemophilia A and B, huntington's disease, and hemoglobinopathies; and proprietary programs in the areas of lysosomal storage disorders. Further, it has ZFP therapeutic research stage programs in the areas of other monogenic diseases, including various immunodeficiencies, as well as central nervous system disorders and cancer immunotherapy. The company has collaboration and license agreements with Shire International GmbH and Biogen Idec Inc.; and strategic partnerships with Sigma-Aldrich Corporation, Dow AgroSciences, LLC, Open Monoclonal Technology, Inc., F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. Sangamo Biosciences, Inc. was founded in 1995 and is headquartered in Richmond, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LANPHIER EDWARD O IIPresident & CEOFeb 17Option Exercise6.8225,000170,500260,000Feb 19 08:05 PM
LANPHIER EDWARD O IIPresident & CEOFeb 17Sale15.6925,000392,150235,000Feb 19 08:05 PM
Ramasastry SairaDirectorFeb 12Option Exercise5.0310,00050,30010,000Feb 13 07:45 PM
Ramasastry SairaDirectorFeb 12Sale15.0010,000150,0000Feb 13 07:45 PM
Wolff Henry WardExec VP & CFOFeb 10Option Exercise3.4510,00034,500218,849Feb 12 08:14 PM
TickerSOL [NYSE]
CompanyReneSola Ltd.
IndustrySemiconductor - Specialized
Market Cap135.50MEPS (ttm)-0.24
P/E-EPS this Y-1.10%
Forward P/E44.33EPS next Y107.90%
PEG-EPS past 5Y-27.00%
P/S0.08EPS next 5Y15.00%
P/B0.92EPS Q/Q94.60%
Dividend-Sales Q/Q-11.20%
Insider Own45.67%Inst Own13.80%
Insider Trans0.00%Inst Trans-4.92%
Short Float9.63%EarningsMar 04/b
Analyst Recom3.50Target Price1.88
Avg Volume977.01K52W Range1.20 - 4.37
Feb-18-15 05:47AMSasol Limited: Change to Dividend Policy and Segmental Reporting PR Newswire
Feb-09-15 09:24AMSasol Limited: Change in Directors' Executive Responsibilities and Optimised Top Managament Structure Announced PR Newswire
Feb-09-15 04:00AMReneSola PV Testing Lab Achieves UL Certification PR Newswire
Feb-06-15 07:28AMSasol Limited: Trading Statement for the Six Months Ended 31 December 2014 PR Newswire
Feb-06-15 07:00AMReneSola Ltd. (SOL): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-05-15 08:51AMReneSola to Report Fourth Quarter and Full Year 2014 Results on March 4, 2015 PR Newswire
Feb-02-15 12:36PMSasol Hosts an Investor Visit to its US Ethane Cracker and Derivatives Project PR Newswire
Jan-28-15 05:15AMSasol Announces Plan to Respond to the Low Oil Price Environment PR Newswire
Dec-22-14 10:06AMSasol Announces Completion of US$4 Billion Credit Facility for its World-Scale Ethane Cracker and Derivatives Complex in Louisiana PR Newswire
Dec-12-14 08:52AMS.Africa's ANC eyes state sell-off to ease power crunch Reuters
ReneSola Ltd, through its subsidiaries, manufactures and sells various solar power products. It operates through two segments, Wafer, and Cell and Module. The company offers virgin polysilicon; mono crystalline and multi crystalline solar wafers; and photovoltaic cells. It also provides mono crystalline and multi crystalline solar modules for use in various residential, commercial, industrial, and other solar power generation systems. In addition, the company offers wafer processing services. It offers its products to the manufacturers of solar cells and modules, distributors, installers, and end users of solar modules. The company operates in Mainland China, Taiwan, Australia, Singapore, Korea, India, Hong Kong, Japan, Germany, Greece, Belgium, Italy, France, the United States, Spain, Czech Republic, England, the Netherlands, and South Africa. ReneSola Ltd was founded in 2005 and is based in Jiashan, the People's Republic of China.
CompanySunPower Corporation
IndustrySemiconductor - Specialized
Market Cap4.29BEPS (ttm)1.51
P/E21.63EPS this Y124.60%
Forward P/E18.17EPS next Y49.00%
PEG9.01EPS past 5Y34.70%
P/S1.42EPS next 5Y2.40%
P/B2.80EPS Q/Q433.30%
Dividend-Sales Q/Q82.40%
Insider Own0.30%Inst Own38.20%
Insider Trans-46.01%Inst Trans-1.38%
Short Float18.82%EarningsFeb 24/b
Analyst Recom1.90Target Price41.08
Avg Volume2.45M52W Range22.75 - 42.07
Feb-25-15 12:00AMTop U.S. Solar Makers Plan Venture to Own Low-Risk Power Plants at Bloomberg
Feb-24-15 11:58AMSunPower beats Street 4Q forecasts AP
Feb-23-15 05:33PMFirst Solar and SunPower plan to create investment vehicle AP
Feb-27-15 08:00AM16 Oakland Schools Now Generating Clean Power With SunPower Systems PR Newswire
Feb-26-15 07:08PM10-K for SunPower Corp. Company Spotlight
Feb-26-15 01:08PMGoogle Pumps $300 Mil Into SolarCity Residential Fund at Investor's Business Daily
Feb-25-15 02:09PMSunPower (SPWR) Stock Price Target Increased Today at Morgan Stanley at TheStreet
Feb-25-15 12:59PMFirst Solar Upgraded, Price Targets Hiked On Yieldco at Investor's Business Daily
Feb-25-15 11:30AMSunEdison (SUNE) Gains 4% on Bullish 2015 Project Outlook - Analyst Blog Zacks
Feb-25-15 10:39AMWhy A First Solar, SunPower YieldCo Is A 'Two-Headed Dragon Feeding The Beast' Benzinga
SunPower Corporation designs, manufactures, and delivers solar systems to residential, commercial, and utility-scale power plant customers worldwide. The company offers solar power components, including panels, balance of system components, and inverters. It also offers rooftop and ground-mounted solar power systems, including residential systems, commercial roof and ground mounted systems, utility and power plant systems, and utility-scale photovoltaic power plants. In addition, the company offers operations and maintenance services, including remote monitoring, and preventative and corrective maintenance services, as well as rapid-response outage restoration and inverter repair services. Further, it leases solar power systems to residential customers; and sells inverters manufactured by third parties. The company serves investors, financial institutions, project developers, electric utilities, independent power producers, commercial and governmental entities, production home builders, residential owners, and small commercial building owners. SunPower Corporation also sells its products to dealers, systems integrators, and distributors. The company was incorporated in 1985 and is headquartered in San Jose, California. SunPower Corporation is a subsidiary of Total Energies Nouvelles Activits USA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCDANIEL THOMAS RDirectorFeb 11Option Exercise0.002,73502,851Feb 13 05:42 PM
Wood Patrick IIIDirectorFeb 11Option Exercise0.002,735028,654Feb 13 05:56 PM
WERNER THOMAS HDirector, Pres and CEODec 02Sale25.8525,000646,285182,934Dec 04 05:35 PM
MCDANIEL THOMAS RDirectorNov 11Option Exercise0.002,55302,669Nov 13 07:49 PM
Wood Patrick IIIDirectorNov 11Option Exercise0.002,553026,919Nov 13 07:35 PM